Nitric oxide vs Sildenafil for pulmonary artery reactivity testing in heart transplantation candidates
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2012, Vol 1, Issue 1
Abstract
In idiopathic pulmonary arterial hypertension (IPAH) nitric oxide (NO) is an agent of choice for pulmonary artery (PA) reactivity testing. Contrary, currently there is no standardized protocol for PA reactivity testing in patients with pulmonary hypertension (PH) associated with left heart disease and several vasodilator agents are suggested for this procedure. We aimed to assess whether standard protocol of PA reactivity testing used in IPAH is useful in patients with severe PH due to severe systolic dysfunction of a left ventricle. During right heart catheterization we assessed hemodynamic parameters in 14 patients at baseline, during NO inhalation and 30 minutes after oral administration of sildenafi l. We observed a significant decrease in PA pressure and resistance, and increase in cardiac index after sildenafil but not after NO administration. We conclude that standard protocol for PA reactivity in IPAH is not useful in patients with PH due to severe left ventricular systolic dysfunction. JRCD 2012; 1: 7–9
Authors and Affiliations
Magdalena Nowacka, Grzegorz Kopeć, Jakub Stępniewski, Piotr Podolec
Keywords
Related Articles
- EP ID EP245370
- DOI 10.20418/jrcd.vol1no1.22
- Views 103
- Downloads 0
“The sciences alone, however, whether natural or physical, are not sufficient to understand the mystery contained within each person”
His Holiness Pope Francis, European Society of Cardiology Congress, Rome, Italy 31st August 2016Dear Readers,Unlike to previous Editorials, let’s start with the last article in this new issue of the Journal – Report form...
Classification of rare cardiovascular diseases and disorders: challenges in categorisation of different diseases
n/a
Eosinophilic myocarditis: Gardia lamblia infestation and Garcinia cambogia. Coincidence or causality? (RCD code: III‑1B.1.o)
Eosinophilic myocarditis is a rare form of myocardial inflammation that may lead to heart failure and death, if left untreated. A previously healthy 26-year-old man was admitted to the department with chest pain and dysp...
JRCD is now an open‑access journal and also accepts high‑quality papers beyond the field of rare cardiovascular diseases and disorders
n/a
Classification of Rare Cardiovascular Diseases (RCD Classification), Krakow 2013
Almost every day brings new reports of a “rare” (“orphan”) disease – a disease that requires multidisciplinary knowledge and particular caution in making diagnostic and therapeutic decisions.The Classification of Rare Ca...